Manorama Industries / Q3-FY26

MANORAMA Q3 FY26 earnings call.

A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveCall date pendingBack to MANORAMA

Revenue

₹363 Cr

verified against source

Revenue YoY

73.3%

reported change

EBITDA

₹98 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
EBITDA (₹ Cr)PositiveWatchNegative
2 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q3 FY26: 98 · Positive source sentimentQ3 FY26Q4 FY26: 367.7 · Positive source sentiment · 2026-05-15Q4 FY26367.798
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Manorama Industries delivered exceptional Q3 FY26 results with INR 363 crore revenue (+73.3% YoY), driven by enhanced value-added product mix and optimized utilization of the upgraded fractionation facility. EBITDA of INR 98 crore maintained robust 27.1% margins, while PAT of INR 68 crore translated to 18.8% net margin. The company raised FY26 revenue guidance to INR 1,300 crore from INR 1,150 crore, reflecting strong demand from chocolate, confectionery, and cosmetic sectors globally. A major INR 460 crore capex program over 2-3 years was announced, targeting 75,000 MT cocoa butter alternatives capacity, 75,000 MT fractionation, 90,000 MT refinery, and a Burkina Faso backward integration facility. Current 85% capacity utilization and 30% debottlenecking expansion to 52,000 MT support near-term growth. Management guides 30%+ revenue growth for FY27 and expects asset turns exceeding 5x on new investments. Gross margin normalized to 44.3% from prior quarter's 52.8%, attributed to seasonal fluctuations and byproduct realizations rather than structural issues. Key risks include raw material price volatility and execution risk on the large multi-project capex rollout.

Colored figures show movement against the previous available record.

Guidance to track

  • Revised upward from INR 1,150 crore, driven by strong Q3 performance and sustained demand momentum across key customer segments.
  • Management indicated the existing 40,000MT capacity with 15% additional headroom and 30% debottlenecking to 52,000MT provides 40-50% growth potential for next 1-2 years.
  • Out of total INR 460 crore capex, approximately INR 300-330 crore is allocated to forward integration projects (CBA, fractionation, refinery) with targeted asset turns exceeding 5x.
  • Current 25-27% margin range confirmed as sustainable baseline; management working to improve over medium-to-longer term through forward/backward integration projects.

Risks flagged

  • GP margin declined to 44.3% from 52.8% in Q2 due to raw material cost fluctuations and byproduct realization changes, though management maintains EBITDA margins are stable at 25-27%.
  • INR 460 crore capex spanning 4 projects (CBA, fractionation, refinery, Burkina Faso) across India and West Africa over 2-3 years requires significant coordination, funding, and execution capability.
  • Cocoa prices corrected 60%+ in a year; analyst questioned whether CBE products would see price compression similar to cocoa butter (which fell from $25,000-30,000/MT peaks). Management maintains cost-plus model insulates pricing, but commodity linkage for CBE not fully resolved.
  • Brazil partnership with Decel Group, expected to deliver 2,000+ MT in FY26, contributed only 'minor' amounts in Q3 with full revenue ramp unclear. Long-term roadmap for revenue contribution was not quantified.

Key quotes

  • We have reported revenues of INR 363 crores which reflects a remarkable year-on-year growth of 73.3%. This strong performance can be attributed to several key factors including an enhanced mix of value added products, the optimized utilization of our newly upgraded fractionation facility and our commitment to operational excellence.
  • Our backward integration from procurement to research and development to supercritical fractionation provides us with unparallel control over quality, cost, supply stability and the confidence of our worldwide customers. This strategic approach positions us as a trusted partner for our customers in the chocolate, confectionary and cosmetic industries.
  • We are primarily relying on our internal cash accruals which are very strong and sufficient enough to support our planned projects over the next two to three years. We already have begun deploying these funds. We already have spent 52 odd crores towards this capex plan.

Research modules

Go one layer deeper.